Company · CIK 0001618835 · SIC 2834 — Pharmaceutical Preparations · OTC
Evofem Biosciences, Inc. · EVFM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2019 AForm 4 → | Feb 27, 4:11 pm EST | Justin J. FileChief Financial Officer | 50,000 | — | — | 230,490 | — | plan? |
| Feb 25, 2019 AForm 4 → | Feb 27, 4:11 pm EST | Saundra L PelletierChief Executive Officer, Director | 150,000 | — | — | 491,813 | — | plan? |
| Feb 25, 2019 AForm 4 → | Feb 27, 4:10 pm EST | Alexander A FitzpatrickGeneral Counsel and Secretary | 50,000 | — | — | 107,623 | — | plan? |
| Feb 25, 2019 AForm 4 → | Feb 27, 4:10 pm EST | Kelly CulwellChief Medical Officer | 50,000 | — | — | 61,985 | — | plan? |
| Feb 25, 2019 AForm 4 → | Feb 27, 4:09 pm EST | Russell BarransChief Commercial Officer | 75,000 | — | — | 87,541 | — | plan? |
| Feb 8, 2019 PForm 4 → | Feb 12, 4:05 pm EST | Invesco Ltd.10% Owner | 425,531 | $2.64 | $1,123,402 | 9,590,688 | +4.64% | plan? |
| Nov 21, 2018 PForm 4 → | Nov 26, 3:07 pm EST | Russell BarransChief Commercial Officer | 279 | $3.55 | $990 | 12,820 | +2.22% | plan? |
| Oct 16, 2018 FForm 4 → | Oct 17, 12:43 pm EDT | Alexander A FitzpatrickGeneral Counsel and Secretary | 17,377 | $3.78 | $65,685 | 57,623 | — | plan? |
| Aug 20, 2018 PForm 4 → | Aug 21, 4:06 pm EDT | Alexander A FitzpatrickGeneral Counsel and Secretary | 5,000 | $2.21 | $11,035 | 75,000 | +7.14% | plan? |
| Aug 16, 2018 PForm 4 → | Aug 20, 6:25 pm EDT | Kelly CulwellChief Medical Officer | 3,000 | $2.24 | $6,720 | 11,985 | +33.4% | plan? |
| Aug 14, 2018 PForm 4 → | Aug 15, 7:09 pm EDT | Thomas G LynchDirector | 100,000 | $2.26 | $225,854 | 175,000 | +133% | plan? |
| Aug 10, 2018 PForm 4 → | Aug 13, 6:50 pm EDT | Russell BarransChief Commercial Officer | 3,715 | $1.98 | $7,356 | 12,541 | +42.1% | plan? |
| Aug 10, 2018 PForm 4 → | Aug 13, 6:48 pm EDT | Saundra L PelletierChief Executive Officer, Director | 10,000 | $2.11 | $21,100 | 341,813 | +3.01% | plan? |
| Jul 2, 2018 AFForm 4 → | Jul 3, 5:03 pm EDT | Russell BarransChief Commercial Officer | 14,506 | $2.46 | $6,986 | 8,826 | — | plan? |
| Jul 2, 2018 AFForm 4 → | Jul 3, 4:59 pm EDT | Justin J. FileChief Financial Officer | 419,510 | $2.46 | $293,995 | 180,490 | — | plan? |
| Jul 2, 2018 AFForm 4 → | Jul 3, 4:58 pm EDT | Saundra L PelletierChief Executive Officer, Director | 1,318,187 | $2.46 | $1,213,240 | 331,813 | — | plan? |
| Jul 2, 2018 AForm 4 → | Jul 3, 4:57 pm EDT | Alexander A FitzpatrickGeneral Counsel and Secretary | 70,000 | — | — | 70,000 | — | plan? |
| Jul 2, 2018 MForm 4 → | Jul 3, 4:56 pm EDT | Thomas G LynchDirector | 75,000 | — | — | 75,000 | — | plan? |
| Jul 2, 2018 AFForm 4 → | Jul 3, 4:54 pm EDT | Kelly CulwellChief Medical Officer | 18,481 | $2.46 | $11,680 | 8,985 | — | plan? |
| May 22, 2018 PForm 4 → | May 24, 3:32 pm EDT | Invesco Ltd.10% Owner | 2,127,659 | $4.69 | $9,978,721 | 9,165,157 | +30.2% | plan? |
| Jun 21, 2016 MForm 4 → | Jun 23, 6:58 pm EDT | Martha J DemskiDirector | 16,393 | $1.13 | $18,524 | 16,393 | — | plan? |
| Dec 28, 2015 SForm 4 → | Dec 30, 5:18 pm EST | Alta Partners VIII, L.P. +4Other | 797,987 | $1.51 | $1,201,680 | 1,339,776 | −37.3% | plan? |
| Dec 17, 2015 SForm 4 → | Dec 21, 5:02 pm EST | Kenneth W LockeChief Scientific Officer | 598 | $1.26 | $753 | 0 | −100% | plan? |
| Dec 17, 2015 SForm 4 → | Dec 21, 4:55 pm EST | Susan A. KnudsonChief Financial Officer | 1,005 | $1.26 | $1,266 | 0 | −100% | plan? |
| Dec 15, 2015 SForm 4 → | Dec 17, 5:00 pm EST | Alta Partners VIII, L.P. +410% Owner | 529,261 | $1.44 | $762,136 | 2,137,763 | −19.8% | plan? |
| Nov 18, 2015 SForm 4 → | Nov 19, 7:31 pm EST | Kenneth W LockeChief Scientific Officer | 6,098 | $8.30 | $50,619 | 293 | −95.4% | plan? |
| Nov 18, 2015 MForm 4 → | Nov 19, 7:31 pm EST | Kenneth W LockeChief Scientific Officer | 6,098 | $8.30 | $50,619 | 6,391 | — | plan? |
| Oct 15, 2015 FForm 4 → | Oct 19, 6:27 pm EDT | George W MahaffeyPresident and CEO, Director | 26,681 | $8.60 | $229,457 | 171,040 | — | plan? |
| Sep 18, 2015 SForm 4 → | Sep 22, 4:36 pm EDT | Christopher KemmererVP, Pharma Dev & Manufacturing | 1,000 | $12.20 | $12,195 | 10,848 | −8.44% | plan? |
| Sep 18, 2015 MForm 4 → | Sep 22, 4:36 pm EDT | Christopher KemmererVP, Pharma Dev & Manufacturing | 1,000 | $1.34 | $1,342 | 11,848 | — | plan? |
| Sep 1, 2015 SForm 4 → | Sep 3, 5:14 pm EDT | Susan A. KnudsonChief Financial Officer | 3,000 | $11.33 | $33,990 | 492 | −85.9% | plan? |
| Sep 1, 2015 MForm 4 → | Sep 3, 5:14 pm EDT | Susan A. KnudsonChief Financial Officer | 3,000 | $1.22 | $3,660 | 3,492 | — | plan? |
| Aug 7, 2015 MForm 4/A → | Aug 17, 6:50 pm EDT | Christopher KemmererVP, Pharma Dev & Manufacturing | 1,000 | $1.34 | $1,342 | 11,848 | — | plan? |
| Aug 7, 2015 SForm 4 → | Aug 10, 7:44 pm EDT | Christopher KemmererVP, Pharma Dev & Manufacturing | 1,000 | $12.88 | $12,880 | 10,848 | −8.44% | plan? amended |
| Aug 7, 2015 MForm 4 → | Aug 10, 7:44 pm EDT | Christopher KemmererVP, Pharma Dev & Manufacturing | 1,000 | $1.22 | $1,220 | 11,848 | — | plan? amended |
| Jun 12, 2015 MForm 4 → | Jun 16, 5:26 pm EDT | Christopher KemmererVP, Pharma Dev & Manufacturing | 10,848 | $1.22 | $13,235 | 10,848 | — | plan? |
| Mar 19, 2015 PForm 4 → | Mar 20, 7:38 pm EDT | George W MahaffeyPresident and CEO, Director | 1,000 | $7.76 | $7,757 | 197,721 | +0.51% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2019 PForm 4 → | Feb 12, 4:05 pm EST | Invesco Ltd.10% Owner | 212,765 | $0.0001 | $21 | 212,765 | — | |
| Nov 28, 2018 AForm 4/A → | Dec 3, 12:51 pm EST | Alexander A FitzpatrickGeneral Counsel and Secretary | 100,000 | — | — | 100,000 | — | |
| Nov 28, 2018 AForm 4/A → | Dec 3, 12:50 pm EST | Justin J. FileChief Financial Officer | 103,500 | — | — | 103,500 | — | |
| Nov 28, 2018 AForm 4/A → | Dec 3, 12:50 pm EST | Saundra L PelletierChief Executive Officer, Director | 284,625 | — | — | 284,625 | — | |
| Nov 28, 2018 AForm 4/A → | Dec 3, 12:50 pm EST | Russell BarransChief Commercial Officer | 100,000 | — | — | 100,000 | — | |
| Nov 28, 2018 AForm 4/A → | Dec 3, 12:49 pm EST | Kelly CulwellChief Medical Officer | 100,000 | — | — | 100,000 | — | |
| Nov 28, 2018 AForm 4 → | Nov 29, 6:11 pm EST | Russell BarransChief Commercial Officer | — | — | — | 100,000 | — | amended |
| Nov 28, 2018 AForm 4 → | Nov 29, 6:11 pm EST | Justin J. FileChief Financial Officer | — | — | — | 103,500 | — | amended |
| Nov 28, 2018 AForm 4 → | Nov 29, 6:10 pm EST | Alexander A FitzpatrickGeneral Counsel and Secretary | — | — | — | 100,000 | — | amended |
| Nov 28, 2018 AForm 4 → | Nov 29, 6:10 pm EST | Kelly CulwellChief Medical Officer | — | — | — | 100,000 | — | amended |
| Nov 28, 2018 AForm 4 → | Nov 29, 6:09 pm EST | Saundra L PelletierChief Executive Officer, Director | — | — | — | 284,625 | — | amended |
| Jul 31, 2018 AForm 4 → | Aug 2, 4:26 pm EDT | Colin RutherfordDirector | — | — | — | 5,550 | — | |
| Jul 31, 2018 AForm 4 → | Aug 2, 4:25 pm EDT | Justin J. FileChief Financial Officer | — | — | — | 114,000 | — | |
| Jul 31, 2018 AForm 4 → | Aug 2, 4:24 pm EDT | Russell BarransChief Commercial Officer | 98,800 | — | — | 98,800 | — | |
| Jul 31, 2018 AForm 4 → | Aug 2, 4:23 pm EDT | Alexander A FitzpatrickGeneral Counsel and Secretary | — | — | — | 104,500 | — | |
| Jul 31, 2018 AForm 4 → | Aug 2, 4:22 pm EDT | Thomas G LynchDirector | — | — | — | 85,500 | — | |
| Jul 31, 2018 AForm 4 → | Aug 2, 4:20 pm EDT | Saundra L PelletierChief Executive Officer, Director | — | — | — | 313,500 | — | |
| Jul 31, 2018 AForm 4 → | Aug 2, 4:16 pm EDT | Kelly CulwellChief Medical Officer | 98,800 | — | — | 98,800 | — | |
| Jul 24, 2018 AForm 4 → | Jul 27, 4:27 pm EDT | Anthony Stephen O'BrienDirector | 12,875 | — | — | 12,875 | — | late |
| Jul 2, 2018 AMForm 4 → | Jul 3, 4:56 pm EDT | Thomas G LynchDirector | 150,000 | — | — | 0 | — | |
| May 22, 2018 PForm 4 → | May 24, 3:32 pm EDT | Invesco Ltd.10% Owner | 2,127,659 | $0.01 | $21,277 | 2,127,659 | — | |
| May 8, 2018 AForm 4 → | May 10, 6:08 pm EDT | Kim P. KamdarDirector | 12,875 | — | — | 12,875 | — | |
| May 8, 2018 AForm 4 → | May 9, 6:37 pm EDT | Gillian GreerDirector | 12,875 | — | — | 12,875 | — | |
| May 8, 2018 AForm 4 → | May 9, 6:35 pm EDT | Thomas G LynchDirector | 12,875 | — | — | 12,875 | — | |
| May 8, 2018 AForm 4 → | May 9, 6:23 pm EDT | Colin RutherfordDirector | 12,875 | — | — | 12,875 | — | |
| May 8, 2018 AForm 4 → | May 9, 6:21 pm EDT | William Walmsley HallDirector | 12,875 | — | — | 12,875 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 8:18 pm EDT | Anthony Stephen O'BrienDirector | 24,691 | — | — | 24,691 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 8:15 pm EDT | Colin RutherfordDirector | 39,691 | — | — | 24,691 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 8:13 pm EDT | Saundra L PelletierChief Executive Officer, Director | 825,000 | — | — | 825,000 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 6:17 pm EDT | Thomas G LynchDirector | 249,691 | — | — | 225,000 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 6:13 pm EDT | William Walmsley HallDirector | 24,691 | — | — | 24,691 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 5:57 pm EDT | Gillian GreerDirector | 24,691 | — | — | 24,691 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 5:19 pm EDT | Alexander A FitzpatrickGeneral Counsel and Secretary | 275,000 | — | — | 275,000 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 5:16 pm EDT | Justin J. FileChief Financial Officer | 300,000 | — | — | 300,000 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 5:16 pm EDT | Kelly CulwellChief Medical Officer | 260,000 | — | — | 260,000 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 5:12 pm EDT | Russell BarransChief Commercial Officer | 260,000 | — | — | 260,000 | — | |
| Jan 17, 2018 AForm 4 → | Jan 18, 5:09 pm EST | Colin RutherfordDirector | 770 | — | — | 770 | — | |
| Jan 17, 2018 AForm 4 → | Jan 18, 5:07 pm EST | Saundra L PelletierChief Executive Officer, Director | 48,795 | — | — | 6,719 | — | |
| Jan 17, 2018 AForm 4 → | Jan 18, 5:05 pm EST | Thomas G LynchDirector | 3,850 | — | — | 3,850 | — | |
| Jan 17, 2018 AForm 4 → | Jan 18, 5:03 pm EST | Justin J. FileChief Financial Officer | 23,099 | — | — | 10,266 | — | |
| Jan 17, 2018 AForm 4 → | Jan 18, 5:01 pm EST | Kelly CulwellChief Medical Officer | 7,699 | — | — | 7,699 | — | |
| Jan 17, 2018 AForm 4 → | Jan 18, 4:59 pm EST | Russell BarransChief Commercial Officer | 5,133 | — | — | 1,283 | — | |
| Jun 22, 2017 AForm 4 → | Jun 23, 4:05 pm EDT | Susan A. KnudsonChief Financial Officer | 65,000 | — | — | 65,000 | — | |
| Jun 22, 2017 AForm 4 → | Jun 23, 4:00 pm EDT | Maria FeldmanVP, Clinical Research | 140,000 | — | — | 140,000 | — | |
| Jun 20, 2017 AForm 4 → | Jun 22, 4:14 pm EDT | Kim P. KamdarDirector, 10% Owner | 12,450 | — | — | 12,450 | — | |
| Jun 20, 2017 AForm 4 → | Jun 21, 9:40 pm EDT | Martha J DemskiDirector | 12,450 | — | — | 12,450 | — | |
| Jun 20, 2017 AForm 4 → | Jun 21, 9:35 pm EDT | Jeffrey M NugentDirector | 12,450 | — | — | 12,450 | — | |
| Jun 20, 2017 AForm 4 → | Jun 21, 9:30 pm EDT | Maxim GorbachevDirector | 12,450 | — | — | 12,450 | — | |
| May 11, 2017 AForm 4 → | May 15, 5:08 pm EDT | Kim P. KamdarDirector, 10% Owner | 63,500 | — | — | 63,500 | — | |
| May 11, 2017 AForm 4 → | May 11, 8:42 pm EDT | Martha J DemskiDirector | 63,500 | — | — | 63,500 | — | |
| May 11, 2017 AForm 4 → | May 11, 8:34 pm EDT | Jeffrey M NugentDirector | 63,500 | — | — | 63,500 | — | |
| Mar 2, 2017 AForm 4 → | Mar 6, 3:55 pm EST | Maria FeldmanVP Clinical Research & Operati | 90,000 | — | — | 90,000 | — | |
| Mar 2, 2017 AForm 4 → | Mar 6, 3:47 pm EST | Susan A. KnudsonChief Financial Officer | 100,000 | — | — | 100,000 | — | |
| Jun 21, 2016 AForm 4 → | Jun 23, 7:08 pm EDT | Maxim GorbachevDirector, 10% Owner | 12,450 | — | — | 12,450 | — | |
| Jun 21, 2016 AForm 4 → | Jun 23, 7:03 pm EDT | Jeffrey M NugentDirector | 37,040 | — | — | 24,590 | — | |
| Jun 21, 2016 AMForm 4 → | Jun 23, 6:58 pm EDT | Martha J DemskiDirector | 69,826 | — | — | 24,590 | — | |
| Jun 21, 2016 AForm 4 → | Jun 23, 4:20 pm EDT | Kim P. KamdarDirector, 10% Owner | 53,433 | — | — | 24,590 | — | |
| Feb 4, 2016 AForm 4 → | Feb 8, 5:52 pm EST | Kenneth W LockeChief Scientific Officer | 35,000 | — | — | 35,000 | — | |
| Feb 4, 2016 AForm 4 → | Feb 8, 5:47 pm EST | Susan A. KnudsonChief Financial Officer | 45,000 | — | — | 45,000 | — | |
| Nov 18, 2015 MForm 4 → | Nov 19, 7:31 pm EST | Kenneth W LockeChief Scientific Officer | 6,098 | — | — | 11,366 | — | |
| Sep 23, 2015 AForm 4 → | Sep 25, 7:01 pm EDT | Hani M ZeiniDirector | 10,179 | — | — | 10,179 | — | |
| Sep 23, 2015 AForm 4 → | Sep 25, 6:53 pm EDT | Jeffrey M NugentDirector | 10,179 | — | — | 10,179 | — | |
| Sep 18, 2015 MForm 4 → | Sep 22, 4:36 pm EDT | Christopher KemmererVP, Pharma Dev & Manufacturing | 1,000 | — | — | 50,182 | — | |
| Sep 1, 2015 MForm 4 → | Sep 3, 5:14 pm EDT | Susan A. KnudsonChief Financial Officer | 3,000 | — | — | 30,718 | — | |
| Aug 7, 2015 MForm 4/A → | Aug 17, 6:50 pm EDT | Christopher KemmererVP, Pharma Dev & Manufacturing | 1,000 | — | — | 51,182 | — | |
| Aug 7, 2015 MForm 4 → | Aug 10, 7:44 pm EDT | Christopher KemmererVP, Pharma Dev & Manufacturing | 1,000 | — | — | 1,710 | — | amended |
| Jun 16, 2015 AForm 4 → | Jun 18, 2:10 pm EDT | Kim P. KamdarDirector, 10% Owner | 36,390 | — | — | 12,450 | — | |
| Jun 16, 2015 AForm 4 → | Jun 17, 9:04 pm EDT | Daniel JanneyDirector, 10% Owner | 36,390 | — | — | 12,450 | — | |
| Jun 16, 2015 AForm 4 → | Jun 17, 9:01 pm EDT | Martha J DemskiDirector | 22,172 | — | — | 12,450 | — | |
| Jun 16, 2015 AForm 4 → | Jun 17, 8:57 pm EDT | Maxim GorbachevDirector, 10% Owner | 36,390 | — | — | 12,450 | — | |
| Jun 12, 2015 MForm 4 → | Jun 16, 5:26 pm EDT | Christopher KemmererVP, Pharma Dev & Manufacturing | 10,848 | — | — | 0 | — | |
| Feb 10, 2015 AForm 4 → | Feb 12, 8:47 pm EST | Kenneth W LockeChief Scientific Officer | 16,288 | — | — | 16,288 | — | |
| Feb 10, 2015 AForm 4 → | Feb 12, 8:42 pm EST | Lincoln KrochmalChief Medical Officer | 16,288 | — | — | 16,288 | — | |
| Feb 10, 2015 AForm 4 → | Feb 12, 8:35 pm EST | Susan A. KnudsonChief Financial Officer | 45,607 | — | — | 45,607 | — | |
| Feb 10, 2015 AForm 4 → | Feb 12, 8:30 pm EST | Christopher KemmererVP, Pharma Dev & Manufacturing | 42,350 | — | — | 42,350 | — |